Results 101 to 110 of about 419 (209)

DEMONSTRATIONS [PDF]

open access: yesBritish Journal of Pharmacology, 1993
openaire   +2 more sources

A Population‐Based Study on Childhood Aplastic Anemia—Incidence, Outcomes, and Health‐Related Quality of Life

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Childhood aplastic anemia (AA) is a rare disease, and both the disease itself and its treatment cause significant morbidity. We aimed to determine the contemporary incidence of childhood AA in Finland, to compare the clinical characteristics of AA against inherited bone marrow failure syndromes (IBMFS) and refractory cytopenia of ...
Lauri‐Matti Kulmala   +8 more
wiley   +1 more source

Demonstrations [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1913
openaire   +2 more sources

The Role of Chemotherapy in Pediatric Myoepithelial Carcinoma: A Systematic Review of the Literature

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Myoepithelial carcinoma (MEC) in pediatric patients is a rare and aggressive malignancy characterized by heterogeneous morphology and variable molecular features. The optimal role of chemotherapy remains unclear. We conducted a systematic review according to PRISMA 2020 guidelines to evaluate chemotherapy in pediatric and young‐adult patients ...
Marco Salvi   +7 more
wiley   +1 more source

Modalys demonstration

open access: yes, 2005
The IRCAM Musical Acoustics Team is not only focused on the muscial instrumetns modelisation research but also on the computer implementation of these models and the evaluation of the musical interest that the computer implementation may have. The physical modelling sound synthesis software Modalys is an environment where virtual acoustical instruments
Ellis, Nicholas   +2 more
openaire   +2 more sources

Determining Parental Factors for Clinical Trial Attrition in Pediatric Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Despite high enrollment rates on Children's Oncology Group (COG) protocols, attrition after initial consent is challenging, introducing bias and prolonging trial completion. While adult oncology literature has identified predictors of withdrawal, little is known about caregiver decision‐making for child participation in ...
Kimberly L. Stathas   +3 more
wiley   +1 more source

Speaker attitude and demonstrative choice in Ncane (Beboid)

open access: yesStudies in African Linguistics, 2018
Ncane is an underdocumented Bantoid language, which offers speakers multiple choices for referring to aforementioned participants. Anaphoric reference is usually made through a noun and an accompanying anaphoric demonstrative.
Richard L. Boutwell
doaj  

Demonstrations Against Demonstrations

open access: yes, 2017
This article shows how, in the midst of the patriotic fervour following the Crimea annexation, the Russian regime used mass demonstrations to pacify the population. Rather than mobilizing people to actively participate in pro-regime, anti-opposition rallies, Kremlin spin doctors used social media to spread moods of sadness and fear in order to ...
openaire   +1 more source

Nephrogenic Rests/Nephroblastomatosis in Patients With Unilateral Wilms Tumor Are Not Associated With an Increased Risk of Relapse: An Analysis of Patients Treated on the SIOP‐WT‐2001 Protocol in the SIOP‐UK‐CCLG and SIOP‐GPOH Studies (2001–2022)

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Nephrogenic rests (NRs) and nephroblastomatosis (NBM) are precursor lesions for development of Wilms tumor (WT). Their association with the risk of relapse has not been properly assessed, partly due to misunderstanding of their diagnostic criteria and terminology.
Gordan M. Vujanić   +5 more
wiley   +1 more source

Administering Blinatumomab via Continuous Intravenous Infusion in Pediatric Patients—A Single‐Institution Retrospective Review

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab, a CD19xCD3 bispecific T‐cell engager, has become standard therapy for children with de novo B‐cell acute lymphoblastic leukemia (B‐ALL). This retrospective review describes the experience of blinatumomab administration in pediatric patients.
Julia M. Hurley   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy